1. Hasan MA, Fitzgerald SM, Saoudian M, et al. Dermatology for the practicing allergist: tinea pedis and its complications. Clin Mol Allergy. 2004; 2–5.
2. Gupta AK, Einarson TR, Summerbell RC, et al. An overview of topical antifungal therapy in dermatomycoses. A North American perspective. Drugs. 1998;55:645–74.
3. Crawford F, Hart R, Bell-Syer S, et al. Topical treatments for fungal infections of the skin and nails of the foot. Cochrane Database Syst Rev. 2000;2, CD001434.
4. •• Parish LC, Parish JL, Routh HB, et al. A randomized, double-blind, vehicle-controlled efficacy and safety study of naftifine 2% cream in the treatment of tinea pedis. J Drugs Dermatol. 2011;10(11):1282–8. This is a randomized, double-blind, vehicle controlled phase 3 trial that demonstrated that two weeks of NAFT-2 is superior to vehicle in treatment of tinea pedis.
5. Weinstein A, Berman B. Topical treatment of common superficial tinea infections. Am Fam Physician. 2002;65(10):2095–103.